34 results
PRER14A
STSS
Sharps Technology Inc
25 Jun 24
Preliminary revised proxy
2:00pm
in the market price of our Common Stock, the increase may not be long-term or permanent. The market price of our Common Stock is dependent on many factors
8-K
EX-99.1
STSS
Sharps Technology Inc
13 Jun 24
Sharps Technology Receives $30 Million Purchase Order for Prefillable Copolymer Syringes to be Manufactured at SC Facility
8:30am
glass designs to support long term drug stability and increase shelf life for pharma and healthcare customers. However, polymer syringes can also
253G3
STSS
Sharps Technology Inc
4 Jun 24
Offering circular supplement
5:03pm
provides for bonus compensation for: (i) closing the Nephron acquisition agreement, (ii) long-term incentives for achieving revenue targets and market … (See Note 5). The agreement provides for bonus compensation for: (i) closing the Nephron acquisition agreement, (ii) long-term incentives for achieving
8-K
EX-10.1
adyd 98ld
20 Dec 23
Departure of Directors or Certain Officers
4:58pm
DEF 14A
q6m26w8l
7 Nov 23
Definitive proxy
8:15am
424B5
7k80ixjbt4eqep9y
29 Sep 23
Prospectus supplement for primary offering
8:00am
8-K
EX-99.1
wokrmonnh2ab2knn8
28 Sep 23
Regulation FD Disclosure
11:27am
8-K
EX-99.1
pqd5zs1pm
26 Sep 23
Signed term sheet providing for up to $75 Million in debt financing to be used for the acquisition
8:45am
S-3/A
z2gmol y6
29 Aug 23
Shelf registration (amended)
4:15pm
S-3
6pnqzi
22 Aug 23
Shelf registration
4:15pm